Regeneron Pharmaceuticals competitorsClear all

Regeneron Pharmaceuticals's top competitors include Catalent, Bristol-Myers Squibb, Idorsia, Amgen, Sanofi and Biogen.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals is a biopharmaceutical company that develops, manufactures, and markets medicines.
Catalent
Catalent
Catalent Pharma Solutions is a company providing integrated services, drug delivery technologies, and manufacturing solutions.
Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing, and delivering medicines for patients with serious and life-threatening diseases.
Idorsia
Idorsia
Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.
Sanofi
Sanofi
Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.
Biogen
Biogen
Biogen is a biopharmaceutical company that discovers, develops, and delivers innovative therapies for people living with serious neurological and neurodegenerative diseases.
Founding Date
Founding Date
1988
Founding Date
2007
Founding Date
1887
Founding Date
2017
Founding Date
1980
Founding Date
2004
Founding Date
1978
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Tarrytown, US HQ
Dublin, IE
Limerick, IE
Uxbridge, GB
Bernards, US
Rensselaer, US
Sleepy Hollow, US
see more
Locations
Franklin Township, US HQ
Loma Hermosa, AR
Bruxelles, BE
Charleroi, BE
Charleroi, BE
Indaiatuba, BR
Sorocaba, BR
see more
Locations
New York, US HQ
Braine L'alleud, BE
Watermaal Bosvoorde, BE
Montréal, CA
Pudong Xinqu, CN
Virum, DK
Espoo, FI
see more
Locations
Allschwil, CH HQ
Shanghai, CN
Lörrach, DE
Chiyoda City, JP
Locations
Thousand Oaks, US HQ
Hydra, DZ
Vicente López, AR
Kew, AU
North Ryde, AU
Wien, AT
Machelen, BE
see more
Locations
Paris, FR HQ
Macquarie Park, AU
Wien, AT
Dhaka, BD
Brussel, BE
Geel, BE
Zaventem, BE
see more
Locations
Cambridge, US HQ
Vicente López, AR
Macquarie Park, AU
Wien, AT
Machelen, BE
Mississauga, CA
see more
Employees
Employees
8,1009% increase
Employees
13,90013% increase
Employees
30,00029% increase
Employees
8007% increase
Employees
23,4009% increase
Employees
100,4094% decrease
Employees
7,4005% decrease
Valuation ($)
Valuation ($)
53.8 b
Valuation ($)
18.8 b
Valuation ($)
146.2 b
Valuation ($)
N/A
Valuation ($)
147.2 b
Valuation ($)
126.4 b
Valuation ($)
41.2 b
Twitter followers
Twitter followers
28 k
Twitter followers
18.9 k
Twitter followers
151.3 k
Twitter followers
1 k
Twitter followers
98.9 k
Twitter followers
140.6 k
Twitter followers
37.8 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
54
Number of tweets (last 30 days)
125
Number of tweets (last 30 days)
67
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
30
Number of tweets (last 30 days)
21
Number of tweets (last 30 days)
23
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
14.8
Average likes per tweet (last 30 days)
1.8
Average likes per tweet (last 30 days)
10.8
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
12.7
Average likes per tweet (last 30 days)
27.4
Average likes per tweet (last 30 days)
19.5
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
98.15%
Percentage of tweets with engagement (last 30 days)
64.8%
Percentage of tweets with engagement (last 30 days)
98.51%
Percentage of tweets with engagement (last 30 days)
66.67%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
95.65%
Alexa Website Rank
Alexa Website Rank
98143
Alexa Website Rank
335605
Alexa Website Rank
101235
Alexa Website Rank
158246
Alexa Website Rank
200877
Alexa Website Rank
123373
Alexa Website Rank
289178
Employee Rating
Employee Rating
4
Employee Rating
3.5
Employee Rating
4.1
Employee Rating
3.4
Employee Rating
4
Employee Rating
3.3
Employee Rating
4.2

Financial

Revenue (est.)
Revenue (est.)
$8.5b (FY, 2020)
Revenue (est.)
$3.1b (FY, 2020)
Revenue (est.)
$42.5b (FY, 2020)
Revenue (est.)
CHF23.8m (FY, 2019)
Revenue (est.)
$25.4b (FY, 2020)
Revenue (est.)
(€926m) (FY, 2020)
Revenue (est.)
$13.4b (FY, 2020)
Cost of goods
Cost of goods
N/A
Cost of goods
$2.1b (FY, 2020)
Cost of goods
$11.8b (FY, 2020)
Cost of goods
N/A
Cost of goods
$6.2b (FY, 2020)
Cost of goods
€12.2b (FY, 2020)
Cost of goods
$1.8b (FY, 2020)
Gross profit
Gross profit
N/A
Gross profit
$983.3m (FY, 2020)
Gross profit
$30.7b (FY, 2020)
Gross profit
N/A
Gross profit
$19.3b (FY, 2020)
Gross profit
(€13.1b) (FY, 2020)
Gross profit
$11.6b (FY, 2020)
Net income
Net income
$3.5b (FY, 2020)
Net income
$220.7m (FY, 2020)
Net income
($9b) (FY, 2020)
Net income
(CHF494.6m) (FY, 2019)
Net income
$7.3b (FY, 2020)
Net income
€12.4b (FY, 2020)
Net income
$4.1b (FY, 2020)

Operating

Countries
Countries
N/A
Countries
85 (FY, 2020)
Countries
N/A
Countries
N/A
Countries
100 (FY, 2019)
Countries
N/A
Countries
N/A
Facilities
Facilities
N/A
Facilities
53 (FY, 2020)
Facilities
N/A
Facilities
N/A
Facilities
190 (FY, 2019)
Facilities
N/A
Facilities
N/A
Patents (EU)
Patents (EU)
11 (FY, 2019)
Patents (EU)
N/A
Patents (EU)
N/A
Patents (EU)
N/A
Patents (EU)
21 (FY, 2019)
Patents (EU)
N/A
Patents (EU)
N/A
Patents (US)
Patents (US)
21 (FY, 2019)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
34 (FY, 2019)
Patents (US)
N/A
Patents (US)
21 (FY, 2019)
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
22 (FY, 2019)
Phase I Trials Products
N/A
Phase I Trials Products
13 (Q3, 2020)
Phase I Trials Products (Oncology)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
19 (FY, 2019)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
12 (FY, 2020)
Phase I Trials Products (Oncology)
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
4 (FY, 2019)
Phase II Trials Products
N/A
Phase II Trials Products
9 (Q3, 2020)
Phase II Trials Products (Oncology)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
14 (FY, 2019)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
6 (FY, 2020)
Phase II Trials Products (Oncology)
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
14 (Feb, 2020)
Phase III Trials Products
N/A
Phase III Trials Products
6 (Q3, 2020)
Products
Products
7 (FY, 2019)
Products
7 k (FY, 2020)
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Products
N/A
Projects in R&D Pipeline
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
44 (FY, 2016)
Projects in R&D Pipeline
12 (FY, 2019)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
91 (FY, 2019)
Projects in R&D Pipeline
N/A

Funding

Total funding raised
Total funding raised
$ 8.9m
Total funding raised
N/A
Total funding raised
$ 15.5m
Total funding raised
N/A
Total funding raised
$ 175.5m
Total funding raised
$ 310m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Catalent
HQ
Franklin Township, US
Employees
13,900↑ 13% increase

Catalent Pharma Solutions is a company providing integrated services, drug delivery technologies, and manufacturing solutions.

View company
Bristol-Myers Squibb
HQ
New York, US
Employees
30,000↑ 29% increase

Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing, and delivering medicines for patients with serious and life-threatening diseases.

View company
Idorsia
HQ
Allschwil, CH
Employees
800↑ 7% increase

Idorsia, a biopharmaceutical company, discovers, develops, and commercializes drugs for unmet medical needs.

View company
Amgen
HQ
Thousand Oaks, US
Employees
23,400↑ 9% increase

Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.

View company